464 related articles for article (PubMed ID: 31028820)
1. Solubility and bioavailability enhancement study of lopinavir solid dispersion matrixed with a polymeric surfactant - Soluplus.
Zi P; Zhang C; Ju C; Su Z; Bao Y; Gao J; Sun J; Lu J; Zhang C
Eur J Pharm Sci; 2019 Jun; 134():233-245. PubMed ID: 31028820
[TBL] [Abstract][Full Text] [Related]
2. Soluplus®/TPGS-based solid dispersions prepared by hot-melt extrusion equipped with twin-screw systems for enhancing oral bioavailability of valsartan.
Lee JY; Kang WS; Piao J; Yoon IS; Kim DD; Cho HJ
Drug Des Devel Ther; 2015; 9():2745-56. PubMed ID: 26045660
[TBL] [Abstract][Full Text] [Related]
3. A New Extrudable Form of Hypromellose: AFFINISOL™ HPMC HME.
Huang S; O'Donnell KP; Keen JM; Rickard MA; McGinity JW; Williams RO
AAPS PharmSciTech; 2016 Feb; 17(1):106-19. PubMed ID: 26335416
[TBL] [Abstract][Full Text] [Related]
4. Development of Tablet Formulation of Amorphous Solid Dispersions Prepared by Hot Melt Extrusion Using Quality by Design Approach.
Agrawal A; Dudhedia M; Deng W; Shepard K; Zhong L; Povilaitis E; Zimny E
AAPS PharmSciTech; 2016 Feb; 17(1):214-32. PubMed ID: 26757898
[TBL] [Abstract][Full Text] [Related]
5. Five-Stage Approach for a Systematic Screening and Development of Etravirine Amorphous Solid Dispersions by Hot-Melt Extrusion.
Simões MF; Pereira A; Cardoso S; Cadonau S; Werner K; Pinto RMA; Simões S
Mol Pharm; 2020 Feb; 17(2):554-568. PubMed ID: 31774685
[TBL] [Abstract][Full Text] [Related]
6. Development of Lipid Polymer Hybrid Drug Delivery Systems Prepared by Hot-Melt Extrusion.
Kasbaum FE; de Carvalho DM; de Jesus Rodrigues L; Cardoso G; Pinho LAG; Martins FT; Cunha-Filho M; Taveira SF; Marreto RN
AAPS PharmSciTech; 2023 Jul; 24(6):156. PubMed ID: 37468721
[TBL] [Abstract][Full Text] [Related]
7. Third-generation solid dispersion combining Soluplus and poloxamer 407 enhances the oral bioavailability of resveratrol.
Vasconcelos T; Prezotti F; Araújo F; Lopes C; Loureiro A; Marques S; Sarmento B
Int J Pharm; 2021 Feb; 595():120245. PubMed ID: 33484925
[TBL] [Abstract][Full Text] [Related]
8. Hot melt extrusion based solid solution approach: Exploring polymer comparison, physicochemical characterization and in-vivo evaluation.
Fule R; Paithankar V; Amin P
Int J Pharm; 2016 Feb; 499(1-2):280-294. PubMed ID: 26746801
[TBL] [Abstract][Full Text] [Related]
9. Application of carrier and plasticizer to improve the dissolution and bioavailability of poorly water-soluble baicalein by hot melt extrusion.
Zhang Y; Luo R; Chen Y; Ke X; Hu D; Han M
AAPS PharmSciTech; 2014 Jun; 15(3):560-8. PubMed ID: 24570374
[TBL] [Abstract][Full Text] [Related]
10. Novel supercritical carbon dioxide impregnation technique for the production of amorphous solid drug dispersions: a comparison to hot melt extrusion.
Potter C; Tian Y; Walker G; McCoy C; Hornsby P; Donnelly C; Jones DS; Andrews GP
Mol Pharm; 2015 May; 12(5):1377-90. PubMed ID: 25730138
[TBL] [Abstract][Full Text] [Related]
11. Enhanced Biopharmaceutical Performance of Rivaroxaban through Polymeric Amorphous Solid Dispersion.
Metre S; Mukesh S; Samal SK; Chand M; Sangamwar AT
Mol Pharm; 2018 Feb; 15(2):652-668. PubMed ID: 29287144
[TBL] [Abstract][Full Text] [Related]
12. Stability-enhanced hot-melt extruded amorphous solid dispersions via combinations of Soluplus® and HPMCAS-HF.
Alshahrani SM; Lu W; Park JB; Morott JT; Alsulays BB; Majumdar S; Langley N; Kolter K; Gryczke A; Repka MA
AAPS PharmSciTech; 2015 Aug; 16(4):824-34. PubMed ID: 25567525
[TBL] [Abstract][Full Text] [Related]
13. Development of hot melt co-formulated antimalarial solid dispersion system in fixed dose form (ARLUMELT): Evaluating amorphous state and in vivo performance.
Fule R; Dhamecha D; Maniruzzaman M; Khale A; Amin P
Int J Pharm; 2015 Dec; 496(1):137-56. PubMed ID: 26471056
[TBL] [Abstract][Full Text] [Related]
14. Extruded Soluplus/SIM as an oral delivery system: characterization, interactions, in vitro and in vivo evaluations.
Zhang Y; Liu Y; Luo Y; Yao Q; Zhong Y; Tian B; Tang X
Drug Deliv; 2016 Jul; 23(6):1902-11. PubMed ID: 25268150
[TBL] [Abstract][Full Text] [Related]
15. Statistical modeling, optimization and characterization of solid self-nanoemulsifying drug delivery system of lopinavir using design of experiment.
Patel G; Shelat P; Lalwani A
Drug Deliv; 2016 Oct; 23(8):3027-3042. PubMed ID: 26882014
[TBL] [Abstract][Full Text] [Related]
16. Increased dissolution and oral absorption of itraconazole/Soluplus extrudate compared with itraconazole nanosuspension.
Zhang K; Yu H; Luo Q; Yang S; Lin X; Zhang Y; Tian B; Tang X
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1285-92. PubMed ID: 23562534
[TBL] [Abstract][Full Text] [Related]
17. Analyzing the impact of different excipients on drug release behavior in hot-melt extrusion formulations using FTIR spectroscopic imaging.
Pudlas M; Kyeremateng SO; Williams LAM; Kimber JA; van Lishaut H; Kazarian SG; Woehrle GH
Eur J Pharm Sci; 2015 Jan; 67():21-31. PubMed ID: 25445833
[TBL] [Abstract][Full Text] [Related]
18. Continuous production of itraconazole-based solid dispersions by hot melt extrusion: Preformulation, optimization and design space determination.
Thiry J; Lebrun P; Vinassa C; Adam M; Netchacovitch L; Ziemons E; Hubert P; Krier F; Evrard B
Int J Pharm; 2016 Dec; 515(1-2):114-124. PubMed ID: 27720874
[TBL] [Abstract][Full Text] [Related]
19. Hot Melt Extrudates Formulated Using Design Space: One Simple Process for Both Palatability and Dissolution Rate Improvement.
Malaquias LFB; Schulte HL; Chaker JA; Karan K; Durig T; Marreto RN; Gratieri T; Gelfuso GM; Cunha-Filho M
J Pharm Sci; 2018 Jan; 107(1):286-296. PubMed ID: 28847477
[TBL] [Abstract][Full Text] [Related]
20. Bottom-Up and Top-Down Approaches to Explore Sodium Dodecyl Sulfate and Soluplus on the Crystallization Inhibition and Dissolution of Felodipine Extrudates.
Chen J; Chen Y; Huang W; Wang H; Du Y; Xiong S
J Pharm Sci; 2018 Sep; 107(9):2366-2376. PubMed ID: 29738699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]